Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
British Journal of Clinical Pharmacology|July 9, 2002
The effect of rizatriptan, ergotamine, and their combination on human peripheral arteries: a double-blind, placebo-controlled, crossover study in normal subjectsPeer Tfelt-Hansen, Kaj Seidelin, Michael Stepanavage, et al.Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 3, 2010
Effect of gaboxadol on patient-reported measures of sleep and waking function in patients with Primary Insomnia: results from two randomized, controlled, 3-month studiesThomas Roth, Christopher Lines, Kristel Vandormael, et al.Journal of Sleep Research|November 19, 2020
Use of the single-item Patient Global Impression-Severity scale as a self-reported assessment of insomnia severityEllen S Snyder, Peining Tao, Vladimir Svetnik, et al.Cephalalgia : an International Journal of Headache|October 13, 2010
Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptanDavid W Dodick, James Kost, Christopher Assaid, et al.Sleep|September 9, 2014
Electroencephalographic power spectral density profile of the orexin receptor antagonist suvorexant in patients with primary insomnia and healthy subjectsJunshui Ma, Vladimir Svetnik, Ellen Snyder, et al.Human Psychopharmacology|November 6, 2008
Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjectsJulia Boyle, Dennis Wolford, Cynthia Gargano, et al.Sleep Medicine|December 18, 2022
Comparison of polysomnography in people with Alzheimer's disease and insomnia versus non-demented elderly people with insomniaPeining Tao, Vladimir Svetnik, Donald L Bliwise, et al.The International Journal of Neuropsychopharmacology|March 22, 2012
Lack of efficacy of L-759274, a novel neurokinin 1 (substance P) receptor antagonist, for the treatment of generalized anxiety disorderDavid Michelson, Richard Hargreaves, Robert Alexander, et al.Sleep Medicine|January 12, 2020
How well can a large number of polysomnography sleep measures predict subjective sleep quality in insomnia patients?Vladimir Svetnik, Ellen S Snyder, Peining Tao, et al.Current Alzheimer Research|January 26, 2012
Pilot randomized controlled study of a histamine receptor inverse agonist in the symptomatic treatment of ADMichael Egan, Roy Yaari, Lian Liu, et al.Pageof 6